Hospitals should put you in the pink, not in the red.
Every October, the pink ribbons and flamingoes come out to raise breast cancer awareness. However, Pink October should go beyond breast cancer awareness to shine the light on women’s health overall, and, as important, the huge responsibility women bear as chief decision makers for their families’ health care.
In the United States, women make 80% of the health-care decisions for their families, yet many of these same women forego their own health care.
A new video released in honor of Pink October is highlighting the fact that a new law has gone into effect that should help women not only better manage their families’ health care, but also help them take better care of themselves. This is critical, as national health-care spending consumes one fifth of the average household budget, and represents nearly one-fifth of GDP, meaning Americans must work the equivalent of one day per week just to pay for their health care.
The video starts with good news: “Thanks to a new federal rule, we Americans have won the right to know the cost of our healthcare before we get it,” says the chipper female narrator. “Imagine that? We get to know the price of our health care before we get smacked with a huge bill we could not see coming.”
Now the chief financial officers of households across America can finally shop for health care the way they shop for everything else: cars, houses, clothing and groceries.
Eventually, a mobile app will let these women buy health care on their devices. Once they no longer have to worry about receiving care that could result in getting a “scary, giant mystery bill” they can stop delaying getting the care they need. Then, maybe fewer women would die of, say, breast cancer.
If that seems too good to be true, so far it is.
Although the new Hospital Price Transparency Final Rule, which went into effect Jan. 1, requires hospitals to post their actual prices — including their discounted cash prices, payer-specific negotiated charges, and de-identified minimum and maximum negotiated charges,— online in an easily accessible format, most are not. A recent report found that that 94.4% of hospitals weren’t following the rule.
Most analysts agree that once health-care price transparency is widespread, which depends on hospitals and ultimately insurers following the transparency rules, competition will enter our price-opaque health-care market, causing prices for care and coverage to plummet. Comparing prices will allow women to find more affordable care, and employers to find more affordable health-plans. Those realized savings could turn into more household income, more jobs, and higher wages.
Yet hospitals are still keeping patients in the dark. Their non-compliance, researchers found, takes many forms:
Making matters worse, the government has yet to fine a single hospital for not complying with the government’s own rule.
As a result, women who finally think they can get the care they and their families need with a guaranteed price cannot.
Fortunately, a national movement is underway to demand prices and it’s gaining traction. From NASCAR to unions, from boardrooms to bedrooms, America is waking up to the fact that they have won the right to know prices.
Now, the government needs to listen to voters not lobbyists and enforce the rule. They need to impose costly fines on hospitals that don’t post actual prices. And the rest of us need to hold our hospitals accountable, demand real prices, not estimates.
It’s time. Our hospitals should put us in the pink, not in the red.
Marni Jameson Carey is the executive director of the Association of Independent Doctors (www.aid-us.org), a national, nonprofit, nonpartisan trade association.
This article was originally published on Medical Economics®.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More